Pacifica Partners
LCTX icon

Pacifica Partners’s Lineage Cell Therapeutics LCTX Stock Holding History

Pacifica Partners’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.63K Hold
2,926
– – ﹤0.01% 368
2026
Q2 		$3.92K Hold
2,926
– – ﹤0.01% 360
2026
Q1 		$4.62K Hold
2,926
– – ﹤0.01% 362
2025
Q4 		$4.8K Hold
2,926
– – ﹤0.01% 340
2025
Q3 		$4.97K Hold
2,926
– – ﹤0.01% 384
2025
Q2 		$2.74K Hold
2,926
– – ﹤0.01% 450
2025
Q1 		$1.22K Hold
2,926
– – ﹤0.01% 476
2024
Q4 		$1.51K Hold
2,926
– – ﹤0.01% 444
2024
Q3 		$2.65K Hold
2,926
– – ﹤0.01% 442
2024
Q2 		$2.67K Hold
2,926
– – ﹤0.01% 451
2024
Q1 		$3.71K Hold
2,926
– – ﹤0.01% 430
2023
Q4 		$2.93K Hold
2,926
– – ﹤0.01% 470
2023
Q3 		$3.83K Hold
2,926
– – ﹤0.01% 433
2023
Q2 		$3.95K Hold
2,926
– – ﹤0.01% 390
2023
Q1 		$4.05K Hold
2,926
– – ﹤0.01% 404
2022
Q4 		$3.08K Hold
2,926
– – ﹤0.01% 397
2022
Q3 		$4K Hold
2,926
– – ﹤0.01% 384
2022
Q2 		$4K Hold
2,926
– – ﹤0.01% 390
2022
Q1 		$4K Hold
2,926
– – ﹤0.01% 386
2021
Q4 		$6K Hold
2,926
– – ﹤0.01% 352
2021
Q3 		$8K Hold
2,926
– – 0.01% 317
2021
Q2 		$8K Hold
2,926
– – 0.01% 308
2021
Q1 		$7K Hold
2,926
– – 0.01% 298
2020
Q4 		$5K Hold
2,926
– – ﹤0.01% 297
2020
Q3 		$3K Hold
2,926
– – ﹤0.01% 297
2020
Q2 		$2K Hold
2,926
– – ﹤0.01% 339
2020
Q1 		$2K Hold
2,926
– – ﹤0.01% 328
2019
Q4 		$3K Buy
+2,926
New +$2.44K ﹤0.01% 313

Other funds holding LCTX

Defender Capital
Defender Capital Charlotte, North Carolina $319M AUM 12.55% 1-Year Est. Return
Hofer & Associates
Hofer & Associates Thousand Oaks, California $143M AUM 11.29% 1-Year Est. Return
Red Crane Wealth Management
Red Crane Wealth Management San Francisco, California $143M AUM 13.63% 1-Year Est. Return
Connecticut Wealth Management
Connecticut Wealth Management Farmington, Connecticut $2.73B AUM 14.39% 1-Year Est. Return
Tableaux
Tableaux Stockbridge, Massachusetts $245M AUM 18.28% 1-Year Est. Return
Beirne Wealth Consulting Services
Beirne Wealth Consulting Services Shelton, Connecticut $505M AUM 16.24% 1-Year Est. Return
Chapin Davis
Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
Founders Capital Management (Texas)
Founders Capital Management (Texas) Houston, Texas $220M AUM 46.36% 1-Year Est. Return
Anchyra Partners
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Pacifica Partners's LCTX Position: Q3 2026 in Review

Pacifica Partners held its Lineage Cell Therapeutics (LCTX) position steady in Q3 2026 at 2,926 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #368.

Pacifica Partners first reported a position in LCTX in Q4 2019 and has held it in 28 quarters since. The position peaked at $8K in Q3 2021. 26 funds tracked by Wall St. Rank hold LCTX as of Q3 2026.

  • Pacifica Partners held 2,926 shares of Lineage Cell Therapeutics worth $2.63K as of Q3 2026.
  • Pacifica Partners left its Lineage Cell Therapeutics share count unchanged in Q3 2026.
  • Lineage Cell Therapeutics made up ﹤0.01% of Pacifica Partners's portfolio in Q3 2026, its #368 holding.
  • Pacifica Partners first reported a position in Lineage Cell Therapeutics in Q4 2019 and has held it in 28 quarters since.
  • Pacifica Partners's Lineage Cell Therapeutics position peaked at $8K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2026.

Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.